Delivery Order SPE2DR25D7005-SPE2DR26F3EXN
Award Date 1/28/26
Potential Completion Date 1/29/26
Potential Value $3.5K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $4,902.80 delivery order to AmerisourceBergen Drug Corp for the supply of Moxifloxacin HCL 400 mg tablets (30-count units) on December 1, 2025, with completion scheduled for December 2, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, to provide Moxifloxacin HCl 400 mg tablets. The potential value of this contract is $1,697.26, with a completion date of February 6, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will perform the work at its Corporate Office location in...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for moxifloxacin HCl 400 mg tablets (unit dose, 50s) with a ceiling value of $1,380.00. This competitive, non-set-aside contract was awarded on July 31, 2025, with a completion date of August 1, 2025. The order will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, under firm fixed-price terms as a delivery order, indicating this is a fulfillment against an...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Moxifloxacin HCL 400 mg tablets in unit dose packaging of 50 units. This competitively awarded, non-set-aside contract has a firm fixed price ceiling value of $2,572.99 with an ultimate completion date of August 7, 2025. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on January 23, 2026, for Moxifloxacin 400mg (30-count supply) valued at $6,513.38. The contract utilizes firm fixed-price pricing with an ultimate completion date of February 20, 2026. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide moxifloxacin hydrochloride. The $3,962.16 order, which has a completion date of December 28, 2023, is part of a larger indefinite delivery contract held by Amerisourcebergen to supply pharmaceuticals and medical supplies to DLA Troop Support Medical facilities. Amerisourcebergen, as the prime contractor, has...
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Moxifloxacin HCL 400 mg tablets. The $5,425.11 firm fixed-price contract has a completion date of September 6, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,493,731 units of Moxifloxacin HCL 400 mg tablets. The contract has a potential value of $11,963.26 and a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations associated with this award. This delivery order is issued...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $1,054.06 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of the pharmaceutical drug moxifloxacin hydrochloride and has a completion date of July 26, 2023. Amerisourcebergen Drug Corp has received numerous similar contract awards from DLA to provide...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,250.65 for Moxifloxacin HCL 400 mg tablets (50 unit dose packages) on July 2, 2025, with an ultimate completion date of July 3, 2025. This competitively awarded, non-set-aside contract is funded through the Defense Logistics Agency's Medical Supply Chain and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order is structured as a firm fixed price arrangement, typical of...